Active, not recruitingNCT05321407
COVID-19 Vaccine Responses in PIDD Subjects
Studying X-linked agammaglobulinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Duke University
- Principal Investigator
- John Sleasman, MD, MDDuke University
- Enrollment
- 100 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2026
Study locations (3)
- University of South Florida, St. Petersburg, Florida, United States
- University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
- Duke University, Durham, North Carolina, United States
Collaborators
Jeffrey Modell Foundation · University of North Carolina, Chapel Hill · University of South Florida · National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05321407 on ClinicalTrials.gov